Search Results - "Kim, Stella K."

First-in-Human, Multicenter, Phase I Dose-Escalation and Expansion Study of Anti-Mesothelin Antibody-Drug Conjugate Anetumab Ravtansine in Advanced or Metastatic Solid Tumors by Hassan, Raffit, Blumenschein, Jr, George R, Moore, Kathleen N, Santin, Alessandro D, Kindler, Hedy L, Nemunaitis, John J, Seward, Shelly M, Thomas, Anish, Kim, Stella K, Rajagopalan, Prabhu, Walter, Annette O, Laurent, Dirk, Childs, Barrett H, Sarapa, Nenad, Elbi, Cem, Bendell, Johanna C

“…This phase I study, which to our knowledge is the first-in-human study of this kind, investigates the safety, tolerability, pharmacokinetics, and clinical…”
Get full text

International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: Proposed Diagnostic Criteria for Chronic GVHD (Part I) by Ogawa, Yoko, Kim, Stella K., Dana, Reza, Clayton, Janine, Jain, Sandeep, Rosenblatt, Mark I., Perez, Victor L., Shikari, Hasanain, Riemens, Anjo, Tsubota, Kazuo

“…The International Chronic Ocular GVHD Consensus Group held 4 working meetings to define new diagnostic metrics for chronic ocular graft-versus-host disease…”
Get full text

Evaluation of Prophylactic Corticosteroid Eye Drop Use in the Management of Corneal Abnormalities Induced by the Antibody-Drug Conjugate Mirvetuximab Soravtansine by Matulonis, Ursula A, Birrer, Michael J, O'Malley, David M, Moore, Kathleen N, Konner, Jason, Gilbert, Lucy, Martin, Lainie P, Bauer, Todd M, Oza, Amit M, Malek, Karim, Pinkas, Jan, Kim, Stella K

“…Reversible, low-grade ocular adverse events (AE) are associated with administration of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeted…”
Get full text

The C-type Lectin Receptor CLECSF8 (CLEC4D) Is Expressed by Myeloid Cells and Triggers Cellular Activation through Syk Kinase by Graham, Lisa M., Gupta, Vandana, Schafer, Georgia, Reid, Delyth M., Kimberg, Matti, Dennehy, Kevin M., Hornsell, William G., Guler, Reto, Campanero-Rhodes, Maria A., Palma, Angelina S., Feizi, Ten, Kim, Stella K., Sobieszczuk, Peter, Willment, Janet A., Brown, Gordon D.

“…Background: C-type lectins play important roles in immunity and homeostasis. Results: CLECSF8 is expressed on neutrophils and monocytes and can mediate…”
Get full text

Self-Consistent Two-Gap Description of MgB2 Superconductor by Kim, Hyunsoo, Cho, Kyuil, Tanatar, Makariy A., Taufour, Valentin, Kim, Stella K., Bud’ko, Sergey L., Canfield, Paul C., Kogan, Vladimir G., Prozorov, Ruslan

“…A self-consistent two-gap γ -model is used to quantitatively describe several thermodynamic properties of MgB 2 superconductor. The superconducting coupling…”
Get full text

Mitigation and management strategies for ocular events associated with tisotumab vedotin by Kim, Stella K., Ursell, Paul, Coleman, Robert L., Monk, Bradley J., Vergote, Ignace

“…Tisotumab vedotin is a tissue factor-directed antibody-drug conjugate developed for treatment of recurrent or metastatic cervical cancer (r/mCC). In the…”
Get full text

Severe periorbital edema secondary to STI571 (Gleevec) by Esmaeli, Bita, Prieto, Victor G., Butler, Charles E., Kim, Stella K., Ahmadi, M. Amir, Kantarjian, Hagop M., Talpaz, Moshe

“…STI571 (imatinib mesylate; Gleevec) is a selective inhibitor of the bcr‐abl, c‐kit, and platelet‐derived growth factor receptor tyrosine kinases. Mild…”
Get full text

Ferromagnetic Quantum Critical Point Avoided by the Appearance of Another Magnetic Phase in LaCrGe3 under Pressure by Taufour, Valentin, Kaluarachchi, Udhara S, Khasanov, Rustem, Nguyen, Manh Cuong, Guguchia, Zurab, Biswas, Pabitra Kumar, Bonfa, Pietro, De Renzi, Roberto, Lin, Xiao, Kim, Stella K

“…The temperature-pressure phase diagram of the ferromagnet LaCrGe3 is determined for the first time from a combination of magnetization, muon-spin-rotation, and…”
Get full text

Ulcerative Keratitis in Gastrointestinal Stromal Tumor Patients Treated with Perifosine by Shome, Debraj, MD, Trent, Jonathan, MD, PhD, Espandar, Ladan, MD, Hatef, Elham, MD, Araujo, Dejka M., MD, Song, C. Diane, MD, Kim, Stella K., MD, Esmaeli, Bita, MD, FACS

“…Purpose Perifosine is a novel alkylphospholipid with antiproliferative properties attributed to protein kinase B inhibition. The authors describe a form of…”
Get full text

Praluzatamab Ravtansine, a CD166-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II Trial by Boni, Valentina, Fidler, Mary J, Arkenau, Hendrik-Tobias, Spira, Alexander, Meric-Bernstam, Funda, Uboha, Nataliya, Sanborn, Rachel E, Sweis, Randy F, LoRusso, Patricia, Nagasaka, Misako, Garcia-Corbacho, Javier, Jalal, Shadia, Harding, James J, Kim, Stella K, Miedema, Iris H C, Vugts, Danielle J, Huisman, Marc C, Zwezerijnen, Gerben J C, van Dongen, Guus A M S, Menke van der Houven van Oordt, C Willemien, Wang, Song, Dang, Tam, Zein, Ivan A, Vasiljeva, Olga, Lyman, Susan K, Paton, Virginia, Hannah, Alison, Liu, Joyce F

“…Praluzatamab ravtansine (CX-2009) is a conditionally activated Probody drug conjugate (PDC) comprising an anti-CD166 mAb conjugated to DM4, with a…”
Get full text

Phase I Trials of Anti-ENPP3 Antibody-Drug Conjugates in Advanced Refractory Renal Cell Carcinomas by Thompson, John A, Motzer, Robert J, Molina, Ana M, Choueiri, Toni K, Heath, Elisabeth I, Redman, Bruce G, Sangha, Randeep S, Ernst, D Scott, Pili, Roberto, Kim, Stella K, Reyno, Leonard, Wiseman, Aya, Trave, Fabio, Anand, Banmeet, Morrison, Karen, Doñate, Fernando, Kollmannsberger, Christian K

“…To determine the safety, pharmacokinetics, and recommended phase II dose of an antibody-drug conjugate (ADC) targeting ectonucleotide…”
Get full text

Phase I dose-escalation study of SGN-75 in patients with CD70-positive relapsed/refractory non-Hodgkin lymphoma or metastatic renal cell carcinoma by Tannir, Nizar M., Forero-Torres, Andres, Ramchandren, Radhakrishnan, Pal, Sumanta K., Ansell, Stephen M., Infante, Jeffrey R., de Vos, Sven, Hamlin, Paul A., Kim, Stella K., Whiting, Nancy C., Gartner, Elaina M., Zhao, Baiteng, Thompson, John A.

“…Summary Purpose This first-in-human study evaluated the CD70-targeted antibody-drug conjugate SGN-75 in patients with relapsed or refractory CD70-positive…”
Get full text

A Phase 3b Study for Management of Ocular Side Effects in Patients with Epidermal Growth Factor Receptor-Amplified Glioblastoma Receiving Depatuxizumab Mafodotin by Vize, Colin J., Kim, Stella K., Matthews, Tim, Macsai, Marian, Merrell, Ryan, Hsu, Sigmund, Kundu, Madan Gopal, Yoon, Jennifer, Kennedy, Emma, Pai, Madhavi, Bain, Earle, Lassman, Andrew B., Moazami, Golnaz

“…Abstract Introduction: The Understanding New Interventions with GBM ThErapy (UNITE) study was designed to assess the effect of prophylaxis for ocular side…”
Get full text

Update on ocular graft versus host disease by Kim, Stella K

“…PURPOSE OF REVIEWTo summarize recent findings regarding the clinical spectrum, pathophysiology, and treatment of ocular graft versus host disease. RECENT…”
Get full text

Histopathologic Diagnosis of Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report by Shulman, Howard M., Kleiner, David, Lee, Stephanie J., Morton, Thomas, Pavletic, Steven Z., Farmer, Evan, Moresi, J. Margaret, Greenson, Joel, Janin, Anne, Martin, Paul J., McDonald, George, Flowers, Mary E.D., Turner, Maria, Atkinson, Jane, Lefkowitch, Jay, Washington, M. Kay, Prieto, Victor G., Kim, Stella K., Argenyi, Zsolt, Diwan, A. Hafeez, Rashid, Asif, Hiatt, Kim, Couriel, Dan, Schultz, Kirk, Hymes, Sharon, Vogelsang, Georgia B.

“…This consensus document provides an update for pathologists and clinicians about the interpretation of biopsy results and use of this information in the…”
Get full text

A Phase II Study of Coltuximab Ravtansine (SAR3419) Monotherapy in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia by Kantarjian, Hagop M, Lioure, Bruno, Kim, Stella K, Atallah, Ehab, Leguay, Thibaut, Kelly, Kevin, Marolleau, Jean-Pierre, Escoffre-Barbe, Martine, Thomas, Xavier G, Cortes, Jorge, Jabbour, Elias, O'Brien, Susan, Bories, Pierre, Oprea, Corina, Hatteville, Laurence, Dombret, Hervé

“…Micro-Abstract Therapy options are limited for adult patients with relapsed or refractory acute lymphoblastic leukemia (ALL). In the present phase II study, 36…”
Get full text

Pathways of Corneal and Ocular Surface Inflammation: A Perspective from the Cullen Symposium by McDermott, Alison M., Perez, Victor, Huang, Andrew J.W., Pflugfelder, Stephen C., Stern, Michael E., Baudouin, Christophe, Beuerman, Roger W., Burns, Alan R., Calder, Virginia L., Calonge, Margarita, Chodosh, James, Coster, Douglas J., Dana, Reza, Hazlett, Linda D., Jones, Dan B., Kim, Stella K., Knop, Erich, Li, De-Quan, Mitchell, Bradley M., Niederkorn, Jerry Y., Pearlman, Eric, Wilhelmus, Kirk R., Kurie, Elaine

“…The goal of this symposium was to coalesce information presented by 22 investigators in the field of corneal and ocular surface inflammation into common…”
Get full text

Histologic features of conjunctival melanoma predictive of metastasis and death (an American Ophthalmological thesis) by Esmaeli, Bita, Roberts, Dianna, Ross, Merrick, Fellman, Melissa, Cruz, Hilda, Kim, Stella K, Prieto, Victor G

“…In conjunctival melanoma, tumor thickness and nonlimbal location are associated with poor prognosis. However, other established high-risk features for…”
Get full text

Bilateral Marginal Keratitis Associated With Engraftment Syndrome After Hematopoietic Stem Cell Transplantation by Dai, Eric, Couriel, Daniel, Kim, Stella K

“…PURPOSE:To report the first case of bilateral marginal keratitis in the setting of engraftment syndrome in a patient who had undergone hematopoietic stem cell…”
Get full text

Ocular Graft vs. Host Disease by Kim, Stella K.

“…Acute graft vs host disease (GVHD) is thought to be mainly a Th1 inflammatory-mediated process, whereas chronic GVHD involves primarily Th2 inflammation. To…”
Get full text